Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

AstraZeneca Group News Editors

News Widget

Display the AstraZeneca Group news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

AstraZeneca Group News

News on AstraZeneca Group (Ticker: AZN) continually updated from thousands of sources around the net.

20 hrs ago | World News Report

Data Presented at the European Atherosclerosis Society Congress ...

Data Presented at the European Atherosclerosis Society Congress Reinforces the Differentiating Benefits of CRESTOR[TM] in Comparison to Atorvastatin and Simvastatin Data presented today from the VOYAGER study demonstrate the benefits of aggressive statin therapy with CRESTOR in comparison to atorvastatin and simvastatin in high risk patients.

Comment?

Related Topix: Atherosclerosis, Health, Lipitor, Atorvastatin (generic), Medication, Zocor, Simvastatin (generic), Biotech

Thu May 24, 2012

CisionWire

Repurchase of Shares in Astrazeneca PLC

AstraZeneca PLC announced that on 23 May 2012, it purchased for cancellation 600,000 ordinary shares of AstraZeneca PLC at a price of 2610 pence per share.

Comment?

Related Topix: AstraZeneca, Biotech, Medicine, Healthcare Industry

BioSpace

EU Big Pharmas Such as AstraZeneca PLC, GlaxoSmithKline, Sanofi...

Drug Giants Such as AstraZeneca PLC , GlaxoSmithKline , Sanofi Join Forces With Academia on $285 Million Antibiotic Pact GlaxoSmithKline and AstraZeneca welcomed the launch of a pioneering approach to antibiotic research in Europe that will see pharmaceutical and biotechnology companies working alongside public partners to tackle the rising threat ... (more)

Comment?

Related Topix: AstraZeneca, Biotech, Medicine, GlaxoSmithKline, Healthcare Industry, MRSA, Health

Tue May 22, 2012

International Business Times

Pre-Market Movers (Trina Solar, Vodafone, Mellanox, AstraZeneca,...

Among the companies whose shares are moving in pre-market trading Tuesday are STMicroelectronics, Ceragon Networks, Trina Solar, Vodafone Group, Mellanox Technologies, Nokia Corp, Cellcom STMicroelectronics NV stock surged 6.07 percent to $5.07 in pre-market session.

Comment?

Related Topix: Vodafone Group, Telecom, Biotech, Semiconductors, Electronics, STMicroelectronics NV, Ceragon Networks, Wireless, Mellanox Technologies, Startups, Nokia

CisionWire

Aterkop av aktier i AstraZeneca PLC 17-21 maj 2012

AstraZeneca PLC announced that on 18 May 2012, it purchased for cancellation 600,000 ordinary shares of AstraZeneca PLC at a price of 2624 pence per share.

Comment?

Related Topix: AstraZeneca, Biotech, Medicine, Healthcare Industry

Mon May 21, 2012

BioSpace

AstraZeneca PLC R&D Chief Forecasts Many Deals to Pad Pipeline

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Having suffered a series of late-stage setbacks, AstraZeneca expects to ink several agreements very soon that will boost its pipeline.

Comment?

Related Topix: AstraZeneca, Biotech, Medicine, Healthcare Industry

Wed May 16, 2012

Stockopedia

Can a management shake-up cure AstraZeneca?

Shareholder revolts have claimed the jobs of a handful of Britain's most high profile bosses in the last couple of months, among them David Brennan, the chief executive of drugs giant AstraZeneca .A After six years in the role, Brennan is leaving under a cloud of concern about the drug giant's ability to replenish its product pipeline at a quicker ... (more)

Comment?

Related Topix: AstraZeneca, Biotech, Medicine, Healthcare Industry

Tue May 15, 2012

BioSpace

Amylin Pharmaceuticals, Inc. Said to Attract Interest From Pfizer...

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Amylin Pharmaceuticals, Inc.

Comment?

Related Topix: Biotech, Medicine, Amylin Pharmaceuticals, Healthcare Industry, Pfizer, Bristol Myers Squibb

Drug Store News

AstraZeneca CEO David Brennan to step down

Executive director and CFO Simon Lowth will act as interim CEO following Brennan's departure, until a new CEO can be found, while VP group finance Julie Brown will become interim CFO.

Comment?

Related Topix: Biotech

Seeking Alpha

Amylin (AMLN) has apparently attracted interest from potential...

Amylin has apparently attracted interest from potential suitors including Pfizer , AstraZeneca , Bristol-Myers and Sanofi , all of which have signed confidentiality agreements on the drugmaker's sale process.

Comment?

Related Topix: Biotech, Medicine, Amylin Pharmaceuticals, Healthcare Industry, Pfizer

CisionWire

Repurchase of Shares in Astrazeneca PLC

AstraZeneca PLC announced that on 14 May 2012, it purchased for cancellation 525,500 ordinary shares of AstraZeneca PLC at a price of 2665 pence per share.

Comment?

Related Topix: AstraZeneca, Biotech, Medicine, Healthcare Industry

Thu May 10, 2012

BioSpace

AstraZeneca PLC Release: SYMBICORT?? (budesonide/formoterol fumarate...

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia AstraZeneca PLC Release: SYMBICORTA Long-Term Study Shows Similar Safety Profile When Compared to Budesonide Monotherapy in African-American Patients with Asthma WILMINGTON, ... (more)

Comment?

Related Topix: Pulmicort, Budesonide (generic), Medicine, Medication, AstraZeneca, Biotech, Healthcare Industry, Foradil, Formoterol (generic), Asthma, Health

Seeking Alpha

AstraZeneca Is Undervalued

AstraZeneca has had a lackluster stock price performance in recent years. Despite the lackluster stock price performance, AstraZeneca sports a high dividend yield of 6.37%, and has increased its dividend rate every year for the last ten years.

Comment?

Related Topix: Biotech

AmericanBankingNews.com

AstraZeneca Now Covered by Analysts at Societe Generale.

AstraZeneca opened at 43.44 on Thursday. AstraZeneca has a 1-year low of $40.89 and a 1-year high of $52.54. The company has a market cap of $55.343 billion and a price-to-earnings ratio of 6.66. AstraZeneca last released its earnings data on Thursday, April 26th.

Comment?

Related Topix: Banking, AstraZeneca, Biotech, Medicine, Healthcare Industry, Bank of America, Financial Services

International Business Times

City Bonuses to Fall by 48%, Says Cebr

Bonus payouts are expected to fall by 48 percent to 2.3bn, year-on-year, according to the latest data from The Centre for Economics and Business Research .

Comment?

Related Topix: Biotech, Trinity Mirror

Wed May 09, 2012

The First Post

Forget the 'shareholder spring' hype: high pay is here to stay

EVERY weekday morning from The Week online - a daily wrap-up of the best comment and opinion articles from the morning papers and the top political bloggers.

Comment?

Related Topix: Twitter, Trinity Mirror, Biotech, Opinion

CisionWire

Repurchase of Shares in Astrazeneca PLC

Further to the announcement of its irrevocable, non-discretionary share repurchase programme for the period 5 March 2012 to 11 May 2012, AstraZeneca PLC announced that under the terms of that programme it purchased for cancellation 313,798 ordinary shares of AstraZeneca PLC at a price of 2709 pence per share on 8 May 2012.

Comment?

Related Topix: AstraZeneca, Biotech, Medicine, Healthcare Industry

This Is London

City Comment: A new aggression causing bosses to watch their backs

The departure of Andrew Moss from his position as chief executive of Aviva, our largest insurance group, comes only days after the forced exit of two other bosses who have disappointed shareholders - Sly Bailey of newspaper publisher Trinity Mirror and David Brennan of pharmaceuticals company AstraZeneca.

Comment?

Related Topix: Trinity Mirror, Biotech

Tue May 08, 2012

IcHounslow

World & UK News: Shareholders force out Aviva chief

Shareholders have claimed another high-profile scalp after Britain's biggest insurer announced the abrupt exit of its chief executive.

Comment?

Related Topix: Biotech, Trinity Mirror

Financial Times

Moss steps down from Aviva helm

Andrew Moss has bowed to investor pressure and stepped down from the helm at Aviva , becoming the latest casualty of shareholder revolt over corporate pay levels.

Comment?

Related Topix: Trinity Mirror, Biotech

Los Angeles Jobs

Also on Topix